Although the hydrogen molecule (H
2) has a low redox potential relative to glutathione, ascorbic acid and α-tocopherol, it has been regarded as an inactive molecule i n vivo. However, recently, many investigators have reported that H
2 exerts a reducing power in vivo, and attention has been given to the in vivo physiological role of H
2. We found that in addition to being transported to the liver via the portal vein, H
2 generated from the fermentation of non-digestible saccharides by bacteria in the large intestine diffused into the abdominal cavity from the lumen of the large intestine before transferring to abdominal tissues, particularly adipose tissue. We have examined the antioxidative effect of colonic H
2 and clarified its suppressive effect on oxidative stress and oxidative damage in the liver. Moreover, increased colonic H
2 transferred to adipose tissue by the administration of non-digestible saccharides decreased the mRNA abundance and secretion of interleukin-6, a proinflammatory cytokine, in high fat-fed rats. Colonic H
2 could contribute to the modulation of adipose redox balance by increased regeneration of α-tocopherol radicals to α-tocopherol through electron donation. Therefore, H
2 produced by colonic fermentation would be a pivotal molecule because it would shift the redox balance toward a more reducing state, resulting in contributions to protection against inflammation and disease. Promotion of fermentation in the large intestine by the administration of non-digestible saccharides, accompanied by increased H
2 production, could prevent disease resulting from increased oxidative stress.
抄録全体を表示